The startup has developed a transposon-based sample prep technology that is able to prepare both small and large RNA molecules in one RNA-seq library.
The UK-based firm recently launched its Nadia system, which is compatible with the Drop-seq protocol, and plans to develop additional applications.
Under the agreement, the companies plan to develop a customized solution that can be widely deployed for DNA sequencing.
The China FDA has approved Vela's cell-free DNA extraction kit, which can be coupled with RT-PCR or NGS workflows for further analysis.
The multi-year renewal includes DNA Genotek's Oragene-Dx saliva kits and GenoFIND services for custom collection kit packaging and order fulfillment services.
The company was spun out of the University of Southern California in 2014 to develop products and services based on a novel sample prep chemistry.
The partners have agreed to codevelop targeted sequencing kits based on single-molecule molecular inversion probes.
Qiagen intends to use System Biosciences' ExoQuick technology in its precipitation-based miRcury Exosome Kits.
The medium has been cleared for transporting samples potentially containing flu A and tuberculosis.
The exclusive two-way licensing deal also allows Akonni to commercialize Righton's molecular diagnostic tests outside of China.
Advanced Analytical markets CE instruments, reagents, and software for nucleic acid analysis while Lasergen is a next-generation sequencing technology developer.
Startup Samplix is developing a droplet-based technique while others are turning to CRISPR/Cas9 as a way to enrich long regions of interest for sequencing.
Streck claims that the blood collection tubes in the Roche Ariosa Harmony kit that Cenata uses infringe its patent.
At the AGBT conference this week, the DNA synthesis discussed the new capture products and its overall business.
The firm plans to integrate its technology with a compatible microfluidic sample prep method developed by researchers at Columbia University.
The Madison, Wisconsin-based company is expanding its global operations with distribution deals in Turkey, South Africa, Russia, and Australia.
The deal covers Circulogene's technology for enriching tumor DNA from small volumes of blood for next-generation sequencing-based analysis.
The Singaporean firm already offers cell-free NIPT testing through its iGene Laboratory and sells a kit to test ovarian cysts for malignancy.
The firm plans to expedite cell sorting for research labs with an inexpensive device that uses piezoelectric actuators and disposable microfluidics.
The SBIR grant will support the development of the firm's single-cell analysis platform, Tapestri.
Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.
The New York Times reports on the shifting interpretations of what some genetic variants mean over time.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.